ArticleMagma (New York, N.Y.)2026
Inclusion of intracranial volume as a covariate feature improves MRI-based Alzheimer's disease classification.
Article in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regional Brain Volume Variation Across Adulthood: A Cross-Sectional MRI Analysis of Age, Sex, and Hemispheric Asymmetry.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveStructural MRI-based regional volumes are widely used for Alzheimer's disease (AD) classification, but inter-individual variability in intracranial volume (ICV) introduces confounding. Traditional adjustment methods use region-of-interest (ROI)/ICV ratios or residual adjustment during pre-processing, yet no consensus exists on the optimal method. This study tests whether explicitly including ICV as a covariate (ROI + ICV) improves classification compared with ratio, residual adjustment, and the unadjusted baseline. MATERIALS AND
methodsT1-weighted MRIs from ADNI1 (n = 1423) and MIRIAD (n = 69) were processed with FreeSurfer to extract eight AD-related ROI volumes and ICV. Four feature configurations (ROI-only, ROI/ICV, Residual ROI, ROI + ICV) were benchmarked across six classifiers for cognitive normal (CN)-AD, CN-mild cognitive impairment (MCI), and MCI-AD. Performance was assessed with AUROC and F1 using Friedman and post hoc tests. In addition, feature attribution was examined with permutation importance and SHAP.
resultsROI + ICV consistently produced the largest performance gains over ROI-only in CN-AD and CN-MCI, outperforming ratio and residual adjustment across most classifiers. These improvements generalized to the independent MIRIAD dataset. SHAP analyses showed that the directional effect of ICV reversed across strategies: under ratio or residual adjustment, larger ICV decreased AD probability, whereas in ROI + ICV, larger ICV increased it. This highlights ICV's contextual influence on model decisions. DISCUSSION: Pre-processing-based adjustments do not fully remove ICV effects and can distort ROI-ICV relationships. Explicit covariate inclusion avoids these issues and yields more consistent, generalizable improvements. Thus, ICV should be modeled rather than removed, making ROI + ICV the preferred default ICV-handling strategy for MRI-based AD classification.
Indexed as
Identifiers
41493686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.